awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36926120-4E7C12AE-E65B-4066-B8BA-BDD36E39D816
Q36926120-4E7C12AE-E65B-4066-B8BA-BDD36E39D816
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36926120-4E7C12AE-E65B-4066-B8BA-BDD36E39D816
Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia AML.
P2860
Q36926120-4E7C12AE-E65B-4066-B8BA-BDD36E39D816
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36926120-4E7C12AE-E65B-4066-B8BA-BDD36E39D816
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d58183fcdb508eedc0c6752b10c752f640a3b0e7
P2860
Patients with acute myeloid leukemia and RAS mutations benefit most from postremission high-dose cytarabine: a Cancer and Leukemia Group B study